Specify a stock or a cryptocurrency in the search bar to get a summary
Zylox-Tonbridge Med Tech Co
2190Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People's Republic of China and internationally. The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products. In addition, the company provides technical consultation and services, as well as imports materials. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China. Address: Zylox-Tonbridge Industrial Park, Hangzhou, China
Analytics
WallStreet Target Price
122.6 HKDP/E ratio
136.75Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 2190
Dividend Analytics 2190
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2190
Stock Valuation 2190
Financials 2190
Results | 2019 | Dynamics |